Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Buyout Pool

View:

Post by spesestsemper on Sep 28, 2024 3:12pm

Buyout Pool

Please keep it light . Basically would like to get everyones opinion on what the buyout number would be if the company gets bought out.

My opinion is still $500 million

145

Comment

Comment by Peladawn on Sep 28, 2024 5:10pm

If they sell out for a mere $500 million, given the likely sales projections of over $5 billion in just one of three indications possible in just the near term, the entire board of directors should be immediately fired and sued, imho.

Comment

Comment by Noteable on Sep 28, 2024 7:04pm

ONCY has $500 million in R&D write-offs and the potential of $US 2.4 Billion in peak annual sales for the 3rd line HR+/HER2- breast cancer alone, and with 13 years of FDA market exclusivity from the approval date of pelareorep. And then there are 2 indications in PDAC, followed by anal cancer, TNBC, CRC and GI cancer indications as follow-on approvals. So US$ 500 million would just ...more

116

Comment

Oncolytics Biotech Inc